1. Immunologic response in gynecologic malignancy·as demonstrated by the delayed hypersensitivity reaction: Clinical correlations
- Author
-
Michael H. Morrow, Philip J. DiSaia, Richard H. Nalick, and Thomas H. Rea
- Subjects
Adult ,Cellular immunity ,Adolescent ,Croton Oil ,Genital Neoplasms, Female ,Uterine Cervical Neoplasms ,Pilot Projects ,Adenocarcinoma ,Trophoblastic Neoplasms ,Skin Diseases ,Uterine Cervical Diseases ,Immune system ,Antigen ,Pregnancy ,Leprosy ,medicine ,Fallopian Tube Neoplasms ,Humans ,Hypersensitivity, Delayed ,Croton oil ,Antigens ,Aged ,Inflammation ,Ovarian Neoplasms ,Immunity, Cellular ,Vulvar Neoplasms ,business.industry ,Carcinoma in situ ,Obstetrics and Gynecology ,Middle Aged ,Nitro Compounds ,medicine.disease ,Fluorobenzenes ,Gynecologic malignancy ,Delayed hypersensitivity ,Dysplasia ,Uterine Neoplasms ,Immunology ,Carcinoma, Squamous Cell ,Female ,business ,Carcinoma in Situ - Abstract
The cell-mediated immune response, as demonstrated by cutaneous delayed hypersensitivity, has been reported to correlate well with the clinical course in a variety of neoplastic diseases. To facilitate evaluation of cellular immunity in patients with gynecologic cancer, an immunologic index has been devised which incorporates the cutaneous reaction to standard antigens, 1-nitro,2,4-difluorobenzene, and croton oil. Thirty-six patients with invasive cervical cancer, 19 patients with cervical dysplasia or carcinoma in situ, and 77 patients with dermatologic disorders were tested. Results reported here indicate a highly significant relationship between host cellular immunity and the clinical course of the patient with a gynecologic neoplasm.
- Published
- 1974